Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxiconazole vs Clotrimazole in Dermatophytosis
NCT07718685Completed
- Sponsor
- Shalamar Institute of Health Sciences
- Start
- Jan 2025
- Primary completion
- Jun 2025
- Countries
- 1
01
Overview
Randomised, open-label trial of oxiconazole in dermatophytosis (2 arms), sponsored by Shalamar Institute of Health Sciences. Primary endpoint: Efficacy in terms of clearance of lesions, pruritis and scaling at 6 months. Started Jan 2025; status: completed.
02
Drugs
oxiconazole
03
Conditions
dermatophytosis
Beyond the preview
Go deeper on NCT07718685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07718685.